Eisai Ltd - Company Review
Eisai Ltd - Company ReviewSummary
Eisai Ltd (Eisai), a subsidiary of Eisai Co Ltd is a research company that discovers, develops and markets therapeutic products. The company’s products include fycompa, halaven, zonegran, zebinix, inovelon, prialt, neurobloc, aricept, and pariet. Its Aricept is used in the treatment of Alzheimer's disease and Pariet for the treatment of gastro-intestinal disorders. Eisai’s Halaven is used for the treatment of metastatic breast cancer and Prialt for severe and chronic pain. The company develops pharmaceutical products in various therapy areas including gastro-intestinal disorders, epilepsy, cervical dystonia and severe and chronic pain. Eisai is headquartered in Hatfield, the UK.
This comprehensive company report of Eisai Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.